The list of patients with brain gliomas evaluated in the present study with their basic characteristics (histopathological diagnosis, WHO grade, gender, age, and overall survival time), as well as promoter DNA methylation of analyzed genes (SFRP1, SFRP2, RUNX3, CBLN4, INA, MGMT, RASSF1A). This evidence concerns the gene RUNX3 and brain glioma.